Biểu đồ giá cổ phiếu HIND
HIND Cổ tức
Vyome Holdings Inc
$2.14
-1.38%
$-0.02
Khi đóng cửa: Aug 05, 16:00:00 GMT-4
$2.15
0.46%
$0
Phiên trước giờ: Aug 06, 09:10:52 GMT-4
Quay lại
Vyome Holdings Inc (HIND) Cổ tức
Thống kê chính
Giá đóng cửa trước
$2.17
Giá mở cửa
$2.14
Phạm vi ngày
$2.14 - $2.2
Phạm vi 52 tuần
$1.75 - $18.6
Khối lượng
9.6K
Khối lượng trung bình
29.4K
Tỷ suất cổ tức
--
EPS (TTM)
-12.41
Vốn hóa thị trường
$15.0M
HIND là gì?
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
